← Back to Search

IVUS GUIDED for Coronary Heart Disease (IGT-PVI Trial)

N/A
Recruiting
Research Sponsored by Philips Clinical & Medical Affairs Global
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up procedure (one visit)
Awards & highlights

IGT-PVI Trial Summary

The main objective of the study is to survey and improve the IVUS image quality and X-ray system interoperability by collecting Procedural Data (e.g. raw, pre- processed ultrasound and X-ray data, endpoints such as fluoroscopy time, contrast load and radiation dose, workflow details) during routine intravascular procedures to assure adherence to the high standards of quality during care delivery and promote procedural standardization.

Eligible Conditions
  • Coronary Heart Disease
  • Peripheral Artery Disease
  • Deep Vein Thrombosis

IGT-PVI Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~procedure (one visit)
This trial's timeline: 3 weeks for screening, Varies for treatment, and procedure (one visit) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Improve
Secondary outcome measures
PROCEDURAL AMOUNT OF CONTRAST USED
PROCEDURAL RADIATION DOSE
Procedural IVUS TIME

IGT-PVI Trial Design

1Treatment groups
Experimental Treatment
Group I: IVUS GUIDEDExperimental Treatment1 Intervention
Those undergoing an already planned IVUS guided treatment for percutaneous vascular interventions

Find a Location

Who is running the clinical trial?

Philips Clinical & Medical Affairs GlobalLead Sponsor
49 Previous Clinical Trials
11,538 Total Patients Enrolled
Eric Secemsky, MDStudy ChairBeth Israel Deaconess Medical Center
1 Previous Clinical Trials
300 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~3333 spots leftby Feb 2028